Literature DB >> 8606051

Feasible criteria for enrolling end-stage dementia patients in home hospice care.

P Hanrahan, D J Luchins.   

Abstract

Hospice care is considered appropriate for end-stage dementia patients (Luchins & Hanrahan, 1993), yet less than 1 percent of hospice patients have a primary diagnosis of dementia (Hanrahan & Luchins, 1995). This pilot study tested the feasibility of providing palliative care for dementia patients. A common eligibility requirement for admission to hospice is that the patient is likely to die within six to seven months. The uncertain survival time of dementia patients thus prevents access to hospice programs. Therefore, enrollment criteria were developed based on the characteristics of advanced dementia and a history of medical complications. With these criteria established, it was then possible to enroll 11 patients over two years. The enrollment criteria proved successful in that the median survival time was five months, with an average of seven months. Eight of the 11 patients died during the study. Hospice care was well accepted by family caregivers and appeared to meet the patient's needs.

Entities:  

Mesh:

Year:  1995        PMID: 8606051     DOI: 10.1080/0742-969x.1995.11882798

Source DB:  PubMed          Journal:  Hosp J        ISSN: 0742-969X


  4 in total

1.  Predictors of mortality in nursing home residents with advanced dementia.

Authors:  Kathryn L Hicks; Peter V Rabins; Betty S Black
Journal:  Am J Alzheimers Dis Other Demen       Date:  2010-07-02       Impact factor: 2.035

Review 2.  The application of palliative care in dementia.

Authors:  Masoumeh Pandpazir; Mozhdeh Tajari
Journal:  J Family Med Prim Care       Date:  2019-02

Review 3.  Primary Palliative Care in Dementia.

Authors:  Neal Weisbrod
Journal:  Neurotherapeutics       Date:  2022-01-26       Impact factor: 6.088

4.  Advanced cognitive impairment among older nursing home residents.

Authors:  Tadeja Gracner; Patricia W Stone; Mansi Agarwal; Mark Sorbero; Susan L Mitchell; Andrew W Dick
Journal:  BMC Geriatr       Date:  2021-06-23       Impact factor: 3.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.